Clinical trial · Observational
Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor
Study on the Molecular Profile and Molecular Signature of Inflammatory Myofibroblastic Tumor
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Gene mutation is a research hotspot in the occurrence of multiple malignant tumors. The somatic gene mutations of many different types of tumors not only help to study the tumorigenesis mechanism and molecular diagnosis, but also can be used as an ideal therapeutic target. Large-scale gene profiling studies performed by humans in various types of epithelial tumors have confirmed some new gene mutations. However, there are few reports on the detection of genes related to inflammatory myofibroblastic tumor, and humans have not yet understood its molecular content. Therefore, it is necessary to further use molecular detection methods to explore the molecular markers of IMT to facilitate its follow-up precise treatment plan.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Inflammatory Myofibroblatic Tumor | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Inflammatory myofibroblastic tumor
- description
- tissue of Inflammatory myofibroblastic tumor lession
Primary outcomes (1)
- measure
- Establishing gene mutation spectrum of patients with inflammatory myofibroblastic tumor
- timeFrame
- through study completion，an average of 1 year
- description
- We sequenced the genes in tissue samples from patients with inflammatory myofibroblastic tumor, and then analyzed the data to obtain a gene map of this type of tumor, and provide data support for the diagnosis and treatment of the disease.
Secondary outcomes (1)
- measure
- Exploring molecular markers for inflammatory myofibroblastic tumor
- timeFrame
- through study completion，an average of 1 year
- description
- We sequenced tissue samples from patients with inflammatory myofibroblastic tumor, and then analyzed the data to explore molecular markers of this type of tumor, and provide assistance in the diagnosis and targeted therapy of the disease.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. From December 2009 to July 2019, patients who were pathologically diagnosed with inflammatory myofibroblastic tumor by Sun Yat-sen University Cancer Center； 2. There are related pathological tissue wax blocks in Sun Yat-sen University Cancer Center; 3. Patient clinical and prognosis tracking data are available. Exclusion Criteria: The patient who has a clinically detectable second primary malignant tumor.
References
Publications (0)
Data not yet available